SNIBE(300832)2024-10-28 08:54Financial Performance - The company's revenue for Q3 2024 reached ¥1,203,339,153.65, representing a 15.38% increase compared to the same period last year[3] - Net profit attributable to shareholders for Q3 2024 was ¥480,442,239.12, up 10.02% year-over-year[3] - The net profit after deducting non-recurring gains and losses was ¥463,458,873.10, reflecting an 11.62% increase from the previous year[3] - In the first three quarters of 2024, the company achieved operating revenue of CNY 3,414.28 million, a year-on-year increase of 17.41%[16] - The total profit for the same period was CNY 1,583.98 million, reflecting a growth of 15.99% year-on-year[16] - The net profit attributable to shareholders was CNY 1,383.59 million, up 16.59% compared to the previous year[16] - The net profit for Q3 2024 reached CNY 1,383,591,276.93, an increase of 16.6% compared to CNY 1,186,704,020.83 in the same period last year[21] - Operating profit for the quarter was CNY 1,601,772,633.01, representing a growth of 17.1% from CNY 1,366,958,518.34 in Q3 2023[21] - The company reported a total comprehensive income of CNY 1,360,509,568.22 for the quarter, compared to CNY 1,248,308,230.92 in Q3 2023, reflecting a growth of 8.9%[22] - Basic earnings per share increased to CNY 1.7609 from CNY 1.5108 in the same quarter last year, marking a rise of 16.5%[22] Assets and Liabilities - Total assets at the end of Q3 2024 amounted to ¥8,836,313,022.27, a 7.47% increase from the end of the previous year[3] - The company's cash and cash equivalents decreased to CNY 568.70 million from CNY 1,048.27 million at the beginning of the period[18] - Total assets increased to CNY 8,836.31 million from CNY 8,222.49 million at the beginning of the period[20] - The total liabilities increased to CNY 717.12 million from CNY 678.09 million at the beginning of the period[20] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥958,084,817.39, showing a 3.35% increase compared to the same period last year[3] - Cash flow from operating activities generated a net amount of CNY 958,084,817.39, slightly up from CNY 927,065,681.24 in the previous year[24] - The net increase in cash and cash equivalents for Q3 2024 was -477,075,709.51, compared to an increase of 328,709,685.18 in the same period last year[25] - The beginning balance of cash and cash equivalents was 1,045,777,126.56, while the ending balance was 568,701,417.05, indicating a significant decrease[25] - The cash and cash equivalents at the end of the period decreased by approximately 29.5% compared to the previous year's ending balance of 806,830,415.09[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 11,629[10] - The largest shareholder, Tibet New Industry Investment Management Co., Ltd., holds 26.88% of shares, totaling 211,177,400 shares[10] - The second-largest shareholder, Rao Wei, holds 13.77% of shares, totaling 108,205,000 shares[10] - The company has a total of 105,511,259 restricted shares at the end of the reporting period, with 18,804,600 shares added during the period[15] - The shareholder Rao Jie has 18,800,025 newly restricted shares[15] - The top ten shareholders collectively hold 99% of the shares[11] - The report indicates that there are no changes in the status of pledged shares among the top shareholders[10] Investment Activities - The company’s investment activities generated a net cash outflow of ¥653,576,032.58, a 1749.50% increase compared to the previous year, primarily due to longer-term financial products purchased[9] - The total cash inflow from investment activities was CNY 5,444,209,003.00, down from CNY 6,233,547,788.78 in the previous year[24] - The company incurred a net cash outflow from investment activities of CNY 653,576,032.58, compared to a smaller outflow of CNY 35,337,954.72 in Q3 2023[24] Research and Development - Research and development expenses amounted to CNY 327,397,980.58, up 20.7% from CNY 271,264,732.85 in the previous year[21] Market Performance - Domestic market main business revenue grew by 13.60%, while overseas market main business revenue increased by 25.16%[16] - Revenue from reagents increased by 17.93%, and revenue from instrument products rose by 16.27% in the first three quarters[16] - The company sold and installed 795 units of the MAGLUMI X8 automated chemiluminescence instrument, with a cumulative total of 3,448 units sold and installed by the end of the reporting period[16] - The new product SATLARS T8 has completed sales and installations of 30 units, indicating market acceptance[16] Other Information - The company has not disclosed any new product or technology developments in this report[15] - There are no significant mergers or acquisitions reported in this quarter[15] - The company has not provided specific future guidance or market expansion strategies in this report[15] - The Q3 2024 report has not been audited, which may affect the reliability of the financial data presented[25]